Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Vitamin K and Bone Turnover in Postmenopausal Women [Phase 3]
A Phase 3 trial evaluating Vitamin K (phylloquinone) on bone turnover in postmenopausal women with osteoporosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Postmenopausal Estrogen/Progestin Interventions (PEPI) [Phase 3]
Phase 3 PEPI trial completed. The study evaluated postmenopausal estrogen/progestin interventions for effects on bone health and cardiovascu…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Evaluation of the Association Between Osteoporosis and Postural Balance in Postmenopausal Women
A completed clinical trial evaluating the association between osteoporosis and postural balance in postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Exercise as an Modulator of Immunological Risk Factors for Osteoporosis [NA]
A completed clinical trial evaluated whether exercise modulates immunological risk factors associated with osteoporosis.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Treatment of Osteopenia With Melatonin [NA]
Completed clinical trial evaluating melatonin for treatment of osteopenia/osteoporosis; results posted in 2016.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females [Phase 1]
A Phase 1 study comparing five formulations of ronacaleret to assess relative bioavailability in healthy postmenopausal women with osteoporo…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients [Phase 3]
Phase 3 trial results are reported for denosumab to prevent osteoporosis in renal transplant recipients; the study is completed with results…
-
CLINICAL_TRIALS research · 2016-04-26Clinical Trial Update: Influence of Osteoporosis on Clinical Outcomes of Mini-invasive Surgical Treatment of Proximal Humerus Fractures
A clinical trial update examining how osteoporosis affects outcomes after mini-invasive surgery for proximal humerus fractures; current stat…
-
CLINICAL_TRIALS research · 2016-04-25Clinical Trial Update: Study of A Special Vessel Subtype in Bone Samples From Patients With Osteoporotic and Nonosteoporotic Fracture [NA]
This clinical trial update describes a study focused on a special vessel subtype in bone samples from patients with osteoporotic and nonoste…
-
CLINICAL_TRIALS research · 2016-04-22Clinical Trial Update: Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038) [NA]
Update on a Merck clinical trial studying management strategies for patients at high risk of osteoporotic fractures.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Osteoporosis Disease Management Demonstration Project (0000-037) [NA]
This clinical trial update reports that the Osteoporosis Disease Management Demonstration Project sponsored by Merck Sharp & Dohme LLC has c…
-
CLINICAL_TRIALS research · 2016-04-19Clinical Trial Update: Understanding and Discouraging Overuse of Potentially Harmful Screening Tests [NA]
Results from a completed clinical trial examining the overuse of potentially harmful preventive screening tests and strategies to discourage…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Women's Health Initiative (WHI) [Phase 3]
The Women's Health Initiative Phase 3 trial status is completed. The update covers osteoporosis, breast cancer, colorectal cancer, and vario…
-
FDA approval · 2016-04-08FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for alendronate sodium filed by Aurobindo Pharma Limited (ANDA 090124).
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Bisphosphonate Therapy for Osteogenesis Imperfecta [Phase 4]
Phase 4 clinical trial update evaluating bisphosphonate therapy for osteogenesis imperfecta; the study is completed and results were posted …
-
FDA approval · 2016-03-29FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for alendronate sodium from Amneal Pharmaceuticals of New York LLC. This action indicates regula…
-
FDA approval · 2016-03-25FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for zoledronic acid filed by Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Effect Of Exercises On Kinesiophobia, And Other Symptoms Related to Osteoporosis [NA]
This completed trial evaluated whether exercise reduces kinesiophobia and other symptoms in individuals with osteoporosis.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: 7 Day Continuous Parathyroid Hormone IV Infusion [EARLY_Phase 1]
An early-phase trial evaluated a 7-day continuous intravenous infusion of parathyroid hormone. The trial focused on osteoporosis and hyperpa…
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: Diagnosis of Decreased Bone Density by Dental Cone Beam Computed Tomography
An update on a clinical trial evaluating dental cone-beam CT for diagnosing decreased bone density in osteoporosis. The trial status is unkn…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Vitamin D Supplementation in Older Women [NA]
Completed clinical trial evaluating Vitamin D supplementation in older women for osteoporosis; no detailed results are provided in the updat…
-
FDA approval · 2016-03-11FDA Approved: IBANDRONATE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approves an Original Application for ibandronate sodium as a generic product (Aurobindo Pharma Limited), enabling its use for osteoporos…
-
CLINICAL_TRIALS research · 2016-03-10Clinical Trial Update: Roles of microRNAs in the Development of Osteoporosis in Men - Preliminary Study
This preliminary study investigates the roles of microRNAs in osteoporosis in men. It represents early-stage research into potential molecul…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI) [Phase 2, Phase 3]
A Phase 2/3 trial comparing functional electrical stimulation (FES) rowing versus zoledronic acid for bone health in spinal cord injury-rela…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. [Phase 2]
Phase 2 randomized trial comparing aromatase inhibition versus testosterone in older men with low testosterone; results completed with poste…